Propranolol-loaded electrospun nanofibrous wound dressing: From fabrication and characterization to preliminary wound healing evaluation

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 221

فایل این مقاله در 13 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-24-9_015

تاریخ نمایه سازی: 24 شهریور 1400

چکیده مقاله:

Objective(s): The wound healing potential of beta-blocker drugs such as propranolol (PNL) has recently attracted attention. To date, incorporation of PNL into electrospun nanofibrous wound dressing mats has not been tested as a novel topical drug delivery system. Presently, electrospun nanofibrous mats loaded with PNL were fabricated, and their physicochemical properties and wound healing activities were evaluated.Materials and Methods: Polyvinyl alcohol solutions containing ۰, ۲% or ۴% (wt/vol) PNL were electrospun into mats, and the physicochemical properties and PNL release were evaluated. In vitro biocompatibility of selected PNL-loaded mats was tested in human foreskin fibroblasts and wound healing capability was evaluated in mouse skin wounds.Results: The ۴% PNL mat had thin fibers (۱۶۰ nm), convincing porosity (۷۹.۵%), and good hydrophilicity (swelling: ۸۹.۱%, water contact angle: ۴۲.۱°) with little degradability (۱۴.۲%). The release of PNL was not in bursts and was best explained by the Korsmeyer–Peppas equation (R۲ = ۰.۹۶, n = ۰.۴۰), suggesting Fickian release. The viability of fibroblasts was ۱۷۳% on day ۵ of incubation with ۴% PNL mats, indicating good mat biocompatibility. In vivo treatment for ۱۴ days with ۴% PNL mats resulted in wounds with a surface area of only ۹% of the original wound area. These wounds had better histopathologic characteristics and were associated with less oxidative stress.Conclusion: The wound dressing fabricated with ۴% PNL showed good potential for wound healing because of a favorable drug release profile from the nanofiber scaffold, and can be considered eligible for further clinical research. 

نویسندگان

Sasan Zaeri

Department of Pharmacology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran

Fatemeh Karami

Department of Pharmacology, School of Pharmacy, Eastern Mediterranean University, Famagusta, North Cyprus

Majid Assadi

Nuclear Medicine and Molecular Imaging Research Center, Bushehr University of Medical Sciences, Bushehr, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Diaconu CC, Marcu DR, Bratu OG, Stanescu AMA, Gheorghe G, ...
  • Marqueling AL, Oza V, Frieden IJ, Puttgen KB. Propranolol and ...
  • Hermans DJJ, van Beynum IM, Kool LJS, van de Kerkhof ...
  • Yang Hy, Fierro F, So M, Yoon DJ, Nguyen AV, ...
  • Chang X, Li S, Xue X, Chang F. Propranolol regulates ...
  • Stojadinovic O, Gordon KA, Lebrun E, Tomic-Canic M. Stress-induced hormones ...
  • Pullar CE, Grahn JC, Liu W, Isseroff RR. β۲‐Adrenergic receptor ...
  • Sivamani RK, Pullar CE, Manabat-Hidalgo CG, Rocke DM, Carlsen RC, ...
  • Pullar CE, Rizzo A, Isseroff RR. beta-Adrenergic receptor antagonists accelerate ...
  • Sorg H, Tilkorn DJ, Hager S, Hauser J, Mirastschijski U. ...
  • Dunnill C, Patton T, Brennan J, Barrett J, Dryden M, ...
  • Cano Sanchez M, Lancel S, Boulanger E, Neviere R. Targeting ...
  • Cha JW, Piao MJ, Kim KC, Yao CW, Zheng J, ...
  • Davel AP, Brum PC, Rossoni LV. Isoproterenol induces vascular oxidative ...
  • Storch C, Hoeger P. Propranolol for infantile haemangiomas: insights into ...
  • Price A, Rai S, Mcleod R, Birchall JC, Elhassan H. ...
  • Singh Malik D, Mital N, Kaur G. Topical drug delivery ...
  • Kumar Chellappan D, Yenese Y, Chian Wei C, Gupta G. ...
  • Tonglairoum P, Ngawhirunpat T, Rojanarata T, Opanasopit P. Lysozyme-immobilized electrospun ...
  • Ahn S, Chantre CO, Gannon AR, Lind JU, Campbell PH, ...
  • Miguel SP, Figueira DR, Simões D, Ribeiro MP, Coutinho P, ...
  • Aljehani AK, Hussaini MA, Hussain MA, Alothmany NS, Aldhaheri RW. ...
  • Yousefi I, Pakravan M, Rahimi H, Bahador A, Farshadzadeh Z, ...
  • Mahdian-Dehkordi M, Sarrafzadeh-Rezaei F, Razi M, Mahmoudian M. Fabrication of ...
  • He W, Ma Z, Yong T, Teo WE, Ramakrishna S. ...
  • Sadri M, Mohammadi A, Hosseini H. Drug release rate and ...
  • Janahmadi Z, Motlagh MR, Zaeri S. Enhancing rat full-thickness skin ...
  • Mæhre HK, Dalheim L, Edvinsen GK, Elvevoll EO, Jensen I-J. ...
  • Premkumar PS. Preparation and electrical studies on pure and oxygen ...
  • Fernandes J, Celestino MT, Tavares MI, Freitas ZM, SANTOS EP, ...
  • Ding W, Wei S, Zhu J, Chen X, Rutman D, ...
  • Karuppuswamy P, Venugopal JR, Navaneethan B, Laiva AL, Ramakrishna S. ...
  • Adepu S, Gaydhane MK, Kakunuri M, Sharma CS, Khandelwal M, ...
  • Lee JH, Yeo Y. Controlled drug release from pharmaceutical nanocarriers. ...
  • Oun R, Plumb JA, Wheate NJ. A cisplatin slow-release hydrogel ...
  • da Silva Marques TZ, Santos-Oliveira R, de Siqueira LBdO, da ...
  • Pullar CE, Le Provost GS, O’leary AP, Evans SE, Baier ...
  • Lee E, Kim DY, Chung E, Lee EA, Park K-S, ...
  • Zheng Z, Liu Y, Yang Y, Tang J, Cheng B. ...
  • Tatmatsu-Rocha JC, Ferraresi C, Hamblin MR, Maia FD, do Nascimento ...
  • Toblli JE, DiGennaro F, Giani JF, Dominici FP. Nebivolol: impact ...
  • Dandekar A, Mendez R, Zhang K. Cross talk between ER ...
  • نمایش کامل مراجع